JULIE MORRIS: Open Payments
NPI 1902255573 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 47 payments from 16 companies in 2025. Trend: 2023 $744 · 2024 $842 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $361 |
| Janssen Biotech, Inc. | 6 | $279 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $276 |
| Madrigal Pharmaceuticals | 4 | $126 |
| Ardelyx, Inc. | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
| Aimmune Therapeutics, Inc. | 2 | $56 |
| PFIZER INC. | 2 | $51 |
| TerSera Therapeutics LLC | 1 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
Products named: TREMFYA, XIFAXAN, LINZESS, REZDIFFRA, IBSRELA, RINVOQ, ENTYVIO, DUPIXENT.
Industry payments across WA — which companies pay providers there.
